| | | | | | | | | | | | |
| | | |
| | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
Current assets | | | | | | | | | | | | |
Cash and cash equivalents | | | 32,145 | | | | 8,483 | | | | 1,331 | |
| | | 653,609 | | | | 414,921 | | | | 65,110 | |
Prepaid expense and other assets | | | 0 | | | | 14,993 | | | | 2,353 | |
Amount due from its subsidiaries and the consolidated VIEs | | | 2,073 | | | | 1,786 | | | | 280 | |
Total current assets | | | 687,827 | | | | 440,183 | | | | 69,074 | |
| | | | | | | | | | | | |
Non-current assets | | | | | | | | | | | | |
| | | 2,552,965 | | | | 3,885,718 | | | | 609,754 | |
| | | | | | | | | | | | |
Total non-current assets | | | 2,552,965 | | | | 3,885,718 | | | | 609,754 | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
Current liabilities | | | | | | | | | | | | |
Accrued expenses and other current liabilities | | | 60,480 | | | | 3,734 | | | | 586 | |
Amount due to its subsidiaries and the consolidated VIEs | | | 0 | | | | 348,741 | | | | 54,725 | |
| | | | | | | | | | | | |
Total current liabilities | | | 60,480 | | | | 352,475 | | | | 55,311 | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
Series Pre-A convertible redeemable preferred shares (US$ 0.000005 par value per share; 241,148,000 and NaN shares authorized, issued and outstanding as of December 31, 2020 and 2021, respectively) | | | 56,185 | | | | 0 | | | | 0 | |
Series A convertible redeemable preferred shares (US$ 0.000005 par value per share; 334,926,000 and NaN shares authorized, issued and outstanding as of December 31, 2020 and 2021, respectively) | | | 129,323 | | | | 0 | | | | 0 | |
Series A+ convertible redeemable preferred shares (US$ 0.000005 par value per share; 157,896,000 and NaN shares authorized, issued and outstanding as of December 31, 2020 and 2021, respectively) | | | 77,520 | | | | 0 | | | | 0 | |
Series B convertible redeemable preferred shares (US$ 0.000005 par value per share; 352,107,646 and NaN shares authorized, issued and outstanding as of December 31, 2020 and 2021, respectively) | | | 497,106 | | | | 0 | | | | 0 | |
Series C convertible redeemable preferred shares (US$ 0.000005 par value per share; 542,794,072 and NaN shares authorized, issued and outstanding as of December 31, 2020 and 2021, respectively) | | | 1,222,224 | | | | 0 | | | | 0 | |
Series C+ convertible redeemable preferred shares (US$ 0.000005 par value per share; 170,632,018 and NaN shares authorized, issued and outstanding as of December 31, 2020 and 2021, respectively) | | | 490,571 | | | | 0 | | | | 0 | |
Series C++ convertible redeemable preferred shares (US$0.000005 par value per share; 120,971,053 and NaN shares authorized, issued and outstanding as of December 31, 2020 and 2021, respectively) | | | 388,925 | | | | 0 | | | | 0 | |
Series D convertible redeemable preferred shares (US$0.000005 par value per share; 517,264,501 and NaN shares authorized, issued and outstanding as of December 31, 2020 and 2021, respectively) | | | 1,975,482 | | | | 0 | | | | 0 | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
Shareholders’ (Deficit)/Equity: | | | | | | | | | | | | |
Ordinary shares (US$ 0.000005 par value; 10,000,000,000 shares authorized , 1,203,526,000 shares issued and
outstanding as of December 31, 2020 ; 8,900,000,000 Class A ordinary shares authorize d , 3,206,653,701 Class A ordinary shares issue d , 3,140,896,631 Class A ordinary shares outstanding as of December 31, 202 1; 1,000,000,000 Class B ordinary sh ares authorize d, 801,904,979 Clas s B ordinary sh ares issued and ou tstanding as of December 31, 20 21) | | | 41
| | | | 134 | | | | 21 | |
| | | — | | | | 7,329,420 | | | | 1,150,146 | |
Accumulated other comprehensive income/(loss) | | | 14,956 | | | | (21,492 | ) | | | (3,373 | ) |
| | | (1,672,021 | ) | | | (3,334,636 | ) | | | (523,277 | ) |
| | | | | | | | | | | | |
Total shareholders’ (deficit)/equity | | | | | | | | | | | | |
| | | | | | | | | | | | |
Total liabilities, mezzanine equity and shareholders’ (deficit)/equity | | | | | | | | | | | | |
| | | | | | | | | | | | |